β2-adrenergic receptor haplotype linked to intubation and mechanical ventilation in children with asthma

Christopher L Carroll1, Kathleen A Sala, Aaron R Zucker

  • 1Department of Pediatrics, Connecticut Children's Medical Center, 282 Washington Street, Hartford, CT 06106, USA. ccarrol@ccmckids.org

Insights

Genetic factors, specifically the Arg16Gly-Gln27Gln haplotype of the beta-2 adrenergic receptor (ADRβ2), significantly increase the risk of intubation in children with severe asthma exacerbations.

Area of Science:

  • Pediatric Pulmonology
  • Medical Genetics
  • Asthma Research

Background:

  • Asthma exacerbations can lead to respiratory failure in children, necessitating intubation and mechanical ventilation.
  • While clinical factors are known, genetic predispositions to severe asthma requiring ventilation are not well understood.
  • The beta-2 adrenergic receptor (ADRβ2) plays a role in bronchodilation and asthma management.

Purpose of the Study:

  • To investigate the association between genetic polymorphisms of the ADRβ2 and the need for intubation and mechanical ventilation in children with severe asthma.
  • To identify specific ADRβ2 genetic variants that may predict a more severe asthma phenotype.

Main Methods:

  • Genotyping of the ADRβ2 gene was performed on 104 children admitted to the ICU for severe asthma exacerbations.
  • The ADRβ2 genotype, specifically at amino acid positions 16 and 27, was analyzed.
  • Associations between ADRβ2 haplotypes and intubation for respiratory failure were statistically evaluated.

Main Results:

  • The Arg16Gly-Gln27Gln haplotype of the ADRβ2 was significantly associated with a higher likelihood of intubation (OR = 4.2; p = .036).
  • No association was found between intubation and clinical factors like age, obesity, race/ethnicity, or NHLBI asthma classification.
  • Children with the identified haplotype showed a trend towards longer ICU stays, though not statistically significant.

Conclusions:

  • The Arg16Gly-Gln27Gln ADRβ2 haplotype is a significant genetic risk factor for intubation in pediatric severe asthma exacerbations.
  • Genetic variations in the ADRβ2 may contribute to the development of a severe asthma phenotype requiring mechanical ventilation.
  • These findings highlight the potential role of pharmacogenetics in managing severe pediatric asthma.
Abstract

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...